SCUBE3 FAQs
← back to SCUBE3
5 questions
FAQs
- What is SCUBE3 and why is it being studied as a potential breakthrough for hair regrowth? SCUBE3 is a signaling protein that made resting hair follicles start growing in mouse experiments in a 2022 study. It has not been tested in people and is not an approved treatment.
- How does SCUBE3 work on hair follicles compared to treatments like minoxidil or finasteride? Laboratory research in mice reports that SCUBE3, a protein released by dermal papilla cells, signals dormant follicles to grow through the TGF-β pathway downstream of Hedgehog; minoxidil and finasteride instead work on blood flow to the follicle and on DHT, and unlike SCUBE3 they have decades of human trial data behind them. SCUBE3 has not been tested in human clinical trials and is not available as a medicine.
- Is SCUBE3 available in topical or injectable form, and how is it usually applied in studies? SCUBE3 is not available as a topical or injectable treatment and is not an approved medicine. In the one published study, the protein was microinjected into mouse skin, including skin carrying grafted human scalp follicles; there are no human clinical trials.
- Can SCUBE3 help people with androgenetic alopecia, or is it meant for other types of hair loss? SCUBE3 has been studied only in mice, including one donor's human follicles grafted onto mice. It has not been tested in people with androgenetic alopecia or any other type of hair loss.
- What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.